Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,515 | -3,813 | -22,458 | -16,999 | -11,883 |
| Depreciation Amortization | 99 | 54 | 205 | 151 | 98 |
| Accounts payable and accrued liabilities | -709 | -424 | -1,918 | -1,544 | -966 |
| Other Working Capital | 541 | 621 | 2,897 | 1,630 | 1,715 |
| Other Operating Activity | 1,751 | 1,021 | 5,511 | 4,036 | 2,519 |
| Operating Cash Flow | $-4,833 | $-2,542 | $-15,763 | $-12,727 | $-8,517 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -74 | -74 | -51 |
| Investing Cash Flow | $N/A | $N/A | $-74 | $-74 | $-51 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | N/A | N/A | N/A |
| Common Stock Issued | 5,813 | 7 | 71 | 71 | 68 |
| Common Stock Repurchased | N/A | N/A | -478 | -478 | -478 |
| Financing Cash Flow | $10,813 | $5,007 | $-407 | $-407 | $-410 |
| Exchange Rate Effect | -34 | -15 | -25 | -30 | -36 |
| Beginning Cash Position | 3,367 | 3,367 | 19,636 | 19,636 | 19,636 |
| End Cash Position | 9,314 | 5,817 | 3,367 | 6,399 | 10,622 |
| Net Cash Flow | $5,946 | $2,450 | $-16,269 | $-13,237 | $-9,014 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,833 | -2,542 | -15,763 | -12,727 | -8,517 |
| Capital Expenditure | N/A | N/A | -74 | -74 | -51 |
| Free Cash Flow | -4,833 | -2,542 | -15,836 | -12,800 | -8,568 |